Jeffrey Zangmeister, MD works in the field of Hematology. He went to The Ohio State University College of Medicine. He has 1 awards "Top MD". Jeffrey Zangmeister is a published doctor and has 6 publications published. The lastest was: 'Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer.' He accepts all Medicare patients.
|
Dr. Leslie A. Andritsos, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Jeffrey A. Jones, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kami J. Maddocks-Christianson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert Wesolowski, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Alison R. Walker, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Poongothai P. Sundaram, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kristie A. Blum, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Mark D. Brownell, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bhavana Bhatnagar, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Charles F. Von Gunten, MD
|
|
Dr. Mark W. Wurster, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Scott R. Scrape, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sean M. Kirby, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David E. Symer, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|